Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 195,917 | 169,383 | 220,501 | 204,547 | 200,262 |
| Cost of Goods | 94,182 | 86,476 | 104,979 | 100,122 | 98,316 |
| Gross Profit | 101,735 | 82,907 | 115,522 | 104,425 | 101,946 |
| Operating Expenses | 140,725 | 211,200 | 134,279 | 152,040 | 114,501 |
| Operating Income | -38,808 | -127,817 | -17,778 | -47,493 | -12,239 |
| Interest Expense | 1,605 | 1,634 | 1,579 | 1,576 | 1,537 |
| Other Income | 5,784 | 5,865 | 3,243 | 1,720 | 826 |
| Pre-tax Income | -34,629 | -123,586 | -16,114 | -47,349 | -12,950 |
| Income Tax | 1,146 | 287 | -261 | 1,621 | 2,106 |
| Net Income Continuous | -35,775 | -123,873 | -15,853 | -48,970 | -15,056 |
| Net Income | $-35,775 | $-123,873 | $-15,853 | $-48,970 | $-15,056 |
| EPS Basic Total Ops | -0.55 | -1.92 | -0.25 | -0.76 | -0.23 |
| EPS Basic Continuous Ops | -0.55 | -1.92 | -0.25 | -0.76 | -0.24 |
| EPS Diluted Total Ops | -0.55 | -1.92 | -0.24 | -0.76 | -0.24 |
| EPS Diluted Continuous Ops | -0.55 | -1.92 | -0.25 | -0.76 | -0.24 |
| EBITDA(a) | $-32,594 | $-123,606 | $-12,830 | $-41,904 | $-6,991 |